| Trial Status | All trial activities ended |
| Dates | Date of activation: 17-Aug-06 Closed on : 24-Jul-08 |
| Data management at EORTC | Full |
| Phase | 2 |
| Randomized trial | Yes |
| Type | Adjuvant |
| Targeted Sample size | EORTC Groups: - - All Groups: 132 |
| Number of steps | 1 |
| Drug | Pemetrexed Cisplatin |
| Study Staff | Paul Germonpre (Study Coordinator) - Universitair Ziekenhuis Antwerpen, Edegem Baktiar Hasan (Statistician) - EORTC Headquarters, Brussels Benedicte Marchal (Project Manager) - EORTC Headquarters, Brussels, benedicte.marchal( at )eortc.be, +32 27741078 |
| Type of cancer | Lung |
| Participating Groups | EORTC Lung Cancer Group(Coordinating Group) |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00389688 |
| EudraCT | 2005-003822-25 |
| Protocol documents in PDF (requires password) | Study documentation |